Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing efficacy, safety, and pharmacokinetics of leuprolide mesylate in children with central precocious puberty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• Leuprolide mesylate (leuprolide mesylate)

Snippet

Sponsor: Foresee Pharmaceuticals Co., Ltd. | Conditions: Puberty; Precocious, Central | Phase 3 | Status: COMPLETED